CORT

Corcept Therapeutics Inc Earnings

$58.66

Earnings Summary

Revenue	$181.89Mn
Net Profits	$30.75Mn
Net Profit Margins	16.9%

Highlights

Revenue:

Corcept Therapeutics Inc’s revenue jumped 34.33% since last year same period to $181.89Mn in the Q4 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -0.36% fall in its revenue since last 3-months.

Net Profits:

Corcept Therapeutics Inc’s net profit fell -1.94% since last year same period to $30.75Mn in the Q4 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -34.15% fall in its net profits since last 3-months.

Net Profit Margins:

Corcept Therapeutics Inc’s net profit margin fell -27% since last year same period to 16.9% in the Q4 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -33.91% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Corcept Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter	0.42
EPS Estimate Current Year	0.42

Highlights

EPS Estimate Current Quarter:

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.42 - a 51.18% jump from last quarter’s estimates.

EPS Estimate Current Year:

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.42.

Key Ratios

Key ratios of the Corcept Therapeutics Inc post its Q4 2024 earnings

Earning Per Share (EPS)

0.26

Highlights

Earning Per Share (EPS):

Corcept Therapeutics Inc’s earning per share (EPS) fell -7.14% since last year same period to 0.26 in the Q4 2024. This indicates that the Corcept Therapeutics Inc has generated -7.14% annual rate of fall in its earning per share (EPS) in the last 4 quarters.